Works matching IS 13657852 AND DT 2015 AND VI 18 AND IP 1
Results: 13
Evaluation of PSF1 as a prognostic biomarker for prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 56, doi. 10.1038/pcan.2014.46
- By:
- Publication type:
- Article
Perioperative outcomes and hospital reimbursement by type of radical prostatectomy: results from a privately insured patient population.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 13, doi. 10.1038/pcan.2014.38
- By:
- Publication type:
- Article
Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 63, doi. 10.1038/pcan.2014.47
- By:
- Publication type:
- Article
Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 25, doi. 10.1038/pcan.2014.40
- By:
- Publication type:
- Article
Global DNA hypomethylation in prostate cancer development and progression: a systematic review.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 1, doi. 10.1038/pcan.2014.45
- By:
- Publication type:
- Article
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 31, doi. 10.1038/pcan.2014.41
- By:
- Publication type:
- Article
Change in PSA velocity is a predictor of overall survival in men with biochemically-recurrent prostate cancer treated with nonhormonal agents: combined analysis of four phase-2 trials.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 49, doi. 10.1038/pcan.2014.44
- By:
- Publication type:
- Article
Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 43, doi. 10.1038/pcan.2014.43
- By:
- Publication type:
- Article
Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 81, doi. 10.1038/pcan.2014.50
- By:
- Publication type:
- Article
The diffusion of minimally invasive radical prostatectomy in the United States: a case study of the introduction of new surgical devices.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 75, doi. 10.1038/pcan.2014.49
- By:
- Publication type:
- Article
The association between race and treatment regret among men with recurrent prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 38, doi. 10.1038/pcan.2014.42
- By:
- Publication type:
- Article
Comparison of patients undergoing laser vaporization of the prostate versus TURP using the ACS-NSQIP database.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 18, doi. 10.1038/pcan.2014.39
- By:
- Publication type:
- Article
Diagnostic prostate biopsy performed in a non-academic center increases the risk of re-classification at confirmatory biopsy for men considering active surveillance for prostate cancer.
- Published in:
- Prostate Cancer & Prostatic Diseases, 2015, v. 18, n. 1, p. 69, doi. 10.1038/pcan.2014.48
- By:
- Publication type:
- Article